Mark Pollack to Prognosis
This is a "connection" page, showing publications Mark Pollack has written about Prognosis.
Connection Strength
0.366
-
D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables. J Consult Clin Psychol. 2013 Dec; 81(6):1100-12.
Score: 0.091
-
Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. J Psychiatr Res. 2008 Oct; 42(14):1176-84.
Score: 0.063
-
Resilience: research evidence and conceptual considerations for posttraumatic stress disorder. Depress Anxiety. 2007; 24(2):139-52.
Score: 0.057
-
Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. J Psychiatr Res. 2002 Jul-Aug; 36(4):229-36.
Score: 0.042
-
New developments in panic disorder. Curr Psychiatry Rep. 2000 Aug; 2(4):353-7.
Score: 0.037
-
Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry. 2016 May; 21(5):680-5.
Score: 0.026
-
Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol. 1993 Aug; 13(4):257-63.
Score: 0.023
-
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006 Jul; 189:20-5.
Score: 0.014
-
Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice. Harv Rev Psychiatry. 2002 Mar-Apr; 10(2):109-14.
Score: 0.010
-
Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years. Am J Psychiatry. 1966 Apr; 122(10):1102-9.
Score: 0.003